Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Juni 2023

Genmab — Juni 2023

Planlagt Fastgjort Låst Flyttet Genmab
702 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • R Offline
    R Offline
    Riis7
    wrote on sidst redigeret af
    #491

    Link Preview Image
    Siden kunne ikke findes | Euroinvestor

    favicon

    Euroinvestor (www.euroinvestor.dk)

    1 Reply Last reply
    0
    • K Offline
      K Offline
      Klarussen
      wrote on sidst redigeret af
      #492

      Halli Hallo. Man vender lige ryggen til og wups så har vi sørme en grøn dag til forandring 🙂

      1 Reply Last reply
      0
      • J Offline
        J Offline
        JKY_VH
        wrote on sidst redigeret af
        #493

        😉

        1 Reply Last reply
        0
        • P Offline
          P Offline
          ProinvestorNEWS
          wrote on sidst redigeret af
          #494

          Video opdatering: Det har ikke stået stille på nyhedsfronten, når det gælder flere af de populære pharma- og biotekselskaber på ProInvestor.com. Først og fremmest om EMA's ønske om undersøgelse af kræftrisikoen i to af Novo Nordisks produkter - er der grund til at være nervøs? Nyheden smitter også af på Zealand Pharmas aktiekurs. ALK-Abellós direktør går af i kølvandet på et dårligt kvartalsregnskab. Og hvad sker der med kursen på Genmab? . https://www.proinvestor.com/boards/113379

          1 Reply Last reply
          0
          • P Offline
            P Offline
            Pensionisten
            wrote on sidst redigeret af
            #495

            Genmab slutter rigtigt pænt i USA - omregnet kurs 2616. Så heller ingrn panik over there. 🙂

            1 Reply Last reply
            0
            • S Offline
              S Offline
              Sukkeralf
              wrote on sidst redigeret af
              #496

              Just a moment...

              favicon

              (firstwordpharma.com)

              1 Reply Last reply
              0
              • P Offline
                P Offline
                ProinvestorNEWS
                wrote on sidst redigeret af
                #497

                Shortpositioner på danske aktier https://www.proinvestor.com/boards/113385

                1 Reply Last reply
                0
                • K Offline
                  K Offline
                  Klarussen
                  wrote on sidst redigeret af
                  #498

                  Tid til defensive aktier igen?

                  1 Reply Last reply
                  0
                  • K Offline
                    K Offline
                    Klarussen
                    wrote on sidst redigeret af
                    #499

                    Genmab meget stabilt på short 0,43%

                    1 Reply Last reply
                    0
                    • R Offline
                      R Offline
                      Riis7
                      wrote on sidst redigeret af
                      #500

                      Kan Genmab ikke stige 2 dage i træk:-) kom nu

                      1 Reply Last reply
                      0
                      • B Offline
                        B Offline
                        bikube
                        wrote on sidst redigeret af
                        #501

                        Jo det kan den da - bare se, hvad der skete for et år siden, vi skal bare have fundet det rigtige udgangspunkt. Hvad var det for øvrigt, der startede opturen 16.juni sidste år.

                        1 Reply Last reply
                        0
                        • R Offline
                          R Offline
                          Riis7
                          wrote on sidst redigeret af
                          #502

                          Det bliver nok ikke i dag;-)

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #503

                            EPCORE DLBCL-1 seems fully recruited. They are extending the duratoin of the trial by 4 years. Outcomes will now be measured for 5 years instead of the intended 2 years. How should i read this? Is this a requirement by the FDA? Or are they now thinking patients could still be active on Epco after 5 years instead of 2? https://classic.clinicaltrials.gov/ct2/history/NCT04628494?B=24&A=23&C=merged#StudyPageTop

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #504

                              GEN1042, 3009 and 3014 were also updated btw

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #505

                                Case report: Successful treatment with daratumumab for pure red cell aplasia in a patient with mixed lymphoid chimerism after ABO-mismatched stem cell transplant for sickle cell disease https://www.frontiersin.org/articles/10.3389/fimmu.2023.1212007/full?utm_source=S-TWT&utm_medium=SNET&utm_campaign=ECO_FIMMU_XXXXXXXX_auto-dlvrit

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #506

                                  E L regarding EPCORE DLBCL-1 study must be because it works better than expected…….possibility for cures maybe. But if they cant file based on interim data then it kind of sucks.

                                  1 Reply Last reply
                                  0
                                  • BulderB Offline
                                    BulderB Offline
                                    Bulder
                                    wrote on sidst redigeret af
                                    #507

                                    Her er det så vi savner en q&a. Vi er afhængige af om nogen spørger ind til det på cc. Hvid de først kan file på RR i 2028 bliver det en langtrækker med epco.

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #508

                                      I hope you are right @Sukkeralf . I do believe interim data can be sufficient for filing

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #509

                                        $XBI Big Biotech #Outflows Return
                                        ~$894M of net outflows
                                        This is the #second #largest week of outflows for the sector this year and marks
                                        the 19th week of outflows out of 25 total weeks in 2023. YTD net fund flow now stands
                                        at ~$7.2B in outflows. https://twitter.com/BiotechAnalysst/status/1672236857281716225

                                        1 Reply Last reply
                                        0
                                        • R Offline
                                          R Offline
                                          Riis7
                                          wrote on sidst redigeret af
                                          #510

                                          folk sælger ud af pharma biotek, har de gjort det meste af 2023, folk vil ha tech i år

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper